Gene Expression Market Size, Share, Growth, Sales Revenue and Key Drivers Analysis Research Report by 2028
Health - Trend Magazine originally published at Health - Trend Magazine
Reports And Data
Market Trends – Increasing focus on gene expression assays for detection of COVID-19 variants
NEW YORK, NY, UNITED STATES, April 15, 2022 /EINPresswire.com/ — The global gene expression market size is expected to reach USD 13.36 Billion in 2028 at a CAGR of 8.1% during the forecast period, according to the latest report by Reports and Data. Increasing application of gene expression profiling to detect variants of COVID-19, rapid advancements in genomics and proteomics research, and growing investments to accelerate development of robust gene expression databases are key factors expected to drive market revenue growth over the forecast period. In addition, increasing focus on development of personalized medicines and growing need to streamline the workflow of genetic analysis are some other key factors expected to boost revenue growth of the market going ahead.
Gene expression is an important process through which gene sequences are transcribed into functional products such as proteins or functional RNAs. The process of gene expression occurs in every organism and is regulated and modulated at several levels. Gene expression and regulation are the foundation of cell development and differentiation that enables cells to adapt to different conditions. Genome-wide analysis of gene expression helps in detection and quantification of transcript levels for every known gene in genome and this whole genome expression analysis is extremely beneficial in identification of cell and tissue phenotypes and in the discovery of novel genes and pathways that are involved in the pathogenesis of disease. For instance, genome-wide analysis of gene expression can be very useful in distinguishing between acute myoblastic leukemia and acute lymphoblastic leukemia which are relatively complex to distinguish using conventional approaches. Increasing application of gene expression profiling in cancer research & development of targeted gene therapies are expected to further boost revenue growth of the market over the forecast period.
Gene expression profiling is becoming a more widely employed technology in the clinical hematology laboratory and is extensively used to test cell of origin to differentiate between different B-cell lymphoma. Gene expression studies necessitate a number of tools that facilitate efficient tool and data integration and this is leading to development of advanced analytical tools and is expected to further drive revenue growth of the market going ahead. However, high costs of gene expression analysis and shortage of skilled professionals are some key factors that could hamper market growth to a certain extent over the forecast period.
Get a sample of the report @
Some Key Highlights from the Report:
Services segment is expected to register significantly fast revenue growth rate over the forecast period attributed to growing demand for high-end gene expression profiling and bioinformatics services, in dose-limited toxicity studies, and availability of wide range of RNA-seq profiling services.
High-Plex capacity segment is expected to account for largest revenue share over the forecast period owing to rising availability of high-throughput and fast multiplex gene analysis for multiplexes expression quantitation, increasing benefits of high-plex gene expression in drug research and biomarkers discovery, and introduction of efficient and affordable multiple solutions.
Clinical diagnostic segment is expected to account for a considerably large revenue share over the forecast period attributable increasing application of gene expression analysis and profiling for early and precise diagnosis of genetic disorders, to understand the disease pathogenesis, and in tracking the progression of disease and its response to therapeutic approaches.
North America is expected to account for largest revenue share in the global market between 2021 and 2028 attributable to increasing availability of more advanced research facilities, rising prevalence of genetic disorders, growing focus on development of personalized medicines, and increasing investments to accelerate genomics and proteomics research.
Major companies profiled in the global market report include Agilent Technologies, QIAGEN N.V., Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Oxford Gene Technology, GE Healthcare, F. Hoffmann-La Roche AG, and Becton, Dickinson, and Company.
To know more about the report @
Gene Expression Market Segmentation:
Product & Services Outlook (Revenue, USD Billion; 2018-2028)
Instrument
PCR
NGS
DNA Microarray
Others
Consumables
Reagents
DNA Chips
Services
Gene Expression Profiling Services
Sequencing Services
Other Services
Bioinformatics Solutions
Capacity Outlook (Revenue, USD Billion; 2018-2028)
Low- To Mid- Plex Gene Expression Analysis
High-Plex Gene Expression Analysis
Application Outlook (Revenue, USD Billion; 2018-2028)
Clinical Diagnostics
Drug Discovery & Development
Biotechnology Research
Others
Global Gene Expression Market Report: Regional Segmentation
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
Italy
France
BENELUX
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
A.E.
South Africa
Rest of MEA
Download Summary @
Global Gene Expression Market: Table of Contents
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary Sources
1.4.2. Secondary Sources
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
Chapter 3. Key Insights
Chapter 4. Global Pharma & Healthcare Market Segmentation
4.1. Global Pharma & Healthcare Market COVID-19 Impact Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers’ analysis
4.2.3. Market restraints analysis
4.3. Technological Insights
4.4. Porter’s Five Forces Analysis
4.5. Regulatory Framework
4.6. Price trend Analysis
4.7. Competitive Metric Space Analysis
Request a customization of the report @
Frequently Asked Questions Answered in the Report:
What is the estimated revenue growth rate of the global Gene Expression market over the forecast period?
What are the major factors driving the global market revenue growth?
Which are the leading manufacturers and suppliers in the global Gene Expression market?
Which regional market is expected to lead in terms of revenue share in the global Gene Expression market over the forecast years?
What are the key outcomes of SWOT analysis and Porter’s Five Forces analysis of the market?
Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.
Browse More Reports:
Exoskeleton Market @
Hernia Mesh Market @
Nucleic Acid Testing Market @
Biochip Market @
Antibody Production Market @
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Tushar Rajput
Reports and Data
+18008193052 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
You just read:
EIN Presswire’s priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content.
As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone’s Internet News Presswire
,
tries to define some of the boundaries that are reasonable in today’s world. Please see our
Editorial Guidelines
for more information.
Health - Trend Magazine originally published at Health - Trend Magazine
More Stories
Beauty-Stem Biomedical Celebrates Grand Opening in Arcadia, Los Angeles
Beauty-Stem Biomedical, a cutting-edge stem cell supplement company, marked a momentous occasion with its grand opening in the vibrant city of Arcadia. The event was a resounding success, drawing health enthusiasts, researchers, and industry leaders from far and wide.
Beauty-Stem Biomedical Grand Opening
Dr. Lin visits Beauty-Stem’s Grand Opening in LA. CD34 Stem cell. Power-Stem Biomedical.
LOS ANGELES, April 12, 2024 (Newswire.com)
–
Beauty-Stem, a subsidiary of Power-Stem Biomedical, has been at the forefront of stem cell research and development since its parent company’s inception in Taiwan back in 2005. With a commitment to innovation and scientific excellence, Beauty-Stem aims to revolutionize health and wellness through advanced stem cell supplements.
- Meet Dr. Chai Ching Lin
The driving force behind Beauty-Stem’s groundbreaking work is none other than Dr. Chai Ching Lin. Armed with dual Ph.D. degrees from Michigan State University, Dr. Lin has been a trailblazer in the field of stem cell biology. Her passion for unraveling the mysteries of cellular rejuvenation led her to become a respected professor in academia, shaping the minds of future scientists since 1996.
“We do believe that regeneration doesn’t have to rely on injection. Stem cell regeneration can come from within,” said Dr. Chai Ching Lin.
- Unveiling CD34 Stem Cell Immunology
At the grand opening, attendees were treated to an awe-inspiring presentation by none other than Dr. Chai Ching Lin herself. The highlight of the evening was the unveiling of her latest masterpiece: the book titled “CD34 Stem Cell Immunology.”
Based on groundbreaking international research, Dr. Lin’s book delves into the remarkable potential of CD34 stem cells. These versatile cells have the ability to transform into immune cells, acting as vigilant defenders against cancer cells and external invaders. The implications for personalized medicine and overall well-being are nothing short of extraordinary.
- Power-Stem Biomedical’s Commitment
In addition to Beauty-Stem’s endeavors, Power-Stem Biomedical has established a state-of-the-art laboratory dedicated to providing the most accurate health inspections for the public. Their unwavering commitment to scientific rigor ensures that every product and service meets the highest standards.
- A Vision for the Future
As the applause echoed through the grand hall, Dr. Lin shared her vision: “We stand on the cusp of a new era in health. Beauty-Stem’s commitment to harnessing the regenerative power of stem cells will redefine how we age, heal, and thrive.”
The grand opening concluded with a promise — a promise that Beauty-Stem Biomedical would continue to push boundaries, unlock cellular secrets, and empower individuals worldwide to embrace vitality and longevity.
In the heart of Arcadia, a revolution was born — one that promises to rewrite the script of human health. Beauty-Stem Biomedical invites you to join this transformative journey toward a brighter, healthier future.
Contact Information:
Beauty-Stem Marketing
Media Department
888-341-7505
Original Source:
Beauty-Stem Biomedical Celebrates Grand Opening in Arcadia, Los Angeles
Revolutionizing Patient Experience: Flyland Recovery Network’s Facilities Implement Volo Bedside Tablets
A patient uses Volo in-room tablets at a Flyland Recovery facility
LAKE WORTH, Fla., April 12, 2024 (Newswire.com)
–
Flyland Recovery Network, a leadin…
Sober Safe Spot is Coming to Thunder Over Louisville
For the first time, Sober Safe Spot will bring their safe zone to Kentucky’s “Thunder Over Louisville” event
Sober Safe Spot’s debut at Thunder over Louisville
Sober Safe Spot to offer safe zone for those in Recovery at Thunder over Louisville
LOUISVILLE, Ky., April 11, 2024 (Newswire.com)
–
While serving as a massive tourist attraction and thrilling kick-off to the annual opening festivities of the famed Kentucky Derby, Thunder Over Louisville presents a significant challenge to those in recovery. As by every large community festival, alcohol and drinking play a huge role in the celebration, and bars and beverage vendors pose triggers at every corner. Without the proper support, holding tight to one’s sobriety through the mayhem of Thunder may feel close to impossible – prompting many individuals in recovery to just opt out and stay home.
But life in recovery is beautiful, and fear of relapse should never stop us from opening our arms to embrace every experience possible. That’s why Sober Safe Spot was conceived. It’s an organization that brings safe, substance-free spaces to recreational and cultural events, allowing the recovery community to come out and celebrate without fear. With large white tents to mark the spot, amazing swag, music, good cheer, and the very best company, Sober Safe Spot brings a zone of safety and support to festivals that would have otherwise felt off-limits to the recovery community.
This year, as requested by the local recovery community, Sober Safe Spot will bring their designated safe space to the annual Thunder Over Louisville Event for the very first time! Their tent will be erected on the Clarksville side of Riverside Drive all day on Saturday, April 20th, beginning at 12:00 p.m. The spot will offer incredible free swag, music, games, food and refreshments (for those registered), and endless love, fun, and support for the recovery community!
For more information, please visit sobersafespot.org.
Press availability upon request or at the event.
Contact Information:
Rachel Alter
Rachel.alter@sobersafespot.org
773-562-1457
Sober Safe Spot is a nonprofit organization facilitated and sponsored by Avenues Alumni. The mission of Sober Safe Spot is to strengthen and support the recovery community by creating safe, substance-free spaces at every major recreational event.
Contact Information:
Rachel Alter
Marketing Director
rachel.alter@sobersafespot.org
773-562-1457
Original Source:
Sober Safe Spot is Coming to Thunder Over Louisville
Sober Safe Spot is Coming to Thunder Over Louisville
For the first time, Sober Safe Spot will bring their safe zone to Kentucky’s “Thunder Over Louisville” event
Sober Safe Spot’s debut at Thunder over Louisville
Sober Safe Spot to offer safe zone for those in Recovery at Thunder over Louisville
LOUISVILLE, Ky., April 11, 2024 (Newswire.com)
–
While serving as a massive tourist attraction and thrilling kick-off to the annual opening festivities of the famed Kentucky Derby, Thunder Over Louisville presents a significant challenge to those in recovery. As by every large community festival, alcohol and drinking play a huge role in the celebration, and bars and beverage vendors pose triggers at every corner. Without the proper support, holding tight to one’s sobriety through the mayhem of Thunder may feel close to impossible – prompting many individuals in recovery to just opt out and stay home.
But life in recovery is beautiful, and fear of relapse should never stop us from opening our arms to embrace every experience possible. That’s why Sober Safe Spot was conceived. It’s an organization that brings safe, substance-free spaces to recreational and cultural events, allowing the recovery community to come out and celebrate without fear. With large white tents to mark the spot, amazing swag, music, good cheer, and the very best company, Sober Safe Spot brings a zone of safety and support to festivals that would have otherwise felt off-limits to the recovery community.
This year, as requested by the local recovery community, Sober Safe Spot will bring their designated safe space to the annual Thunder Over Louisville Event for the very first time! Their tent will be erected on the Clarksville side of Riverside Drive all day on Saturday, April 20th, beginning at 12:00 p.m. The spot will offer incredible free swag, music, games, food and refreshments (for those registered), and endless love, fun, and support for the recovery community!
For more information, please visit sobersafespot.org.
Press availability upon request or at the event.
Contact Information:
Rachel Alter
Rachel.alter@sobersafespot.org
773-562-1457
Sober Safe Spot is a nonprofit organization facilitated and sponsored by Avenues Alumni. The mission of Sober Safe Spot is to strengthen and support the recovery community by creating safe, substance-free spaces at every major recreational event.
Contact Information:
Rachel Alter
Marketing Director
rachel.alter@sobersafespot.org
773-562-1457
Original Source:
Sober Safe Spot is Coming to Thunder Over Louisville
h2o Announces FDA Listing of Apple Watch-Based Cueing Feature ‘Foggy’ for Freezing of Gait in Parkinson’s Disease
The innovative new feature within the Parky app for Apple Watch is available by prescription for people with Parkinson’s disease.
ANKARA, Turkey, April 11, 2024 (Newswire.com)
–
h2o therapeutics today announced that Foggy, the company’s haptic cueing feature, is now available by prescription. The feature is classified as a Class II Medical Device by the U.S. Food and Drug Administration (FDA).
Parkinson’s disease affects millions worldwide, presenting unique challenges to both patients and caregivers. Freezing of gait is when someone may have temporary episodes of an inability to step forward. This abnormal gait pattern, in particular, significantly impacts mobility and independence, often leading to falls and decreased quality of life.
Foggy uses the Taptic Engine in Apple Watch to provide vibrotactile stimulation for individuals experiencing freezing of gait, a debilitating symptom of Parkinson’s disease. Users can simply tap a complication on their Apple Watch to initiate haptic feedback that helps with the condition.
“Cueing strategies hold immense promise in aiding individuals with freezing of gait,” says Yagmur Selin Gulmus, founder of h2o therapeutics. “However, the key to their effectiveness lies in accessibility, individualization, and ease of use. Our introduction of Foggy marks a significant advancement in the field, offering patients a non-invasive solution by simply wearing their Apple Watch, designed to assist without adding cognitive load.”
h2o conducted two clinical studies to explore different cueing methods, including audio and visual cues using augmented reality. By collaborating closely with the Parkinson’s community, the company gained valuable insights into patients’ specific needs and preferences. In response, h2o developed Foggy, a user-friendly app tailored to the unique requirements of people living with Parkinson’s disease.
“We’re excited to launch Foggy on World Parkinson’s Day, highlighting a major step in our fight against the tricky problem of freezing of gait, a condition full of unknowns,” explains Gulmus. “Foggy is a starting point towards tackling this issue that only a wealth of real-world data can clarify. Besides haptic cue generation, Foggy also acts as a data platform. This allows us to better understand freezing of gait and individualize our technology to meet the specific needs of those experiencing it.”
In 2022, h2o therapeutics obtained 510(k) marketing clearance from the U.S. Food and Drug Administration for its prescription mobile app, Parky, designed for monitoring Parkinson’s Disease. Integrated into Parky is the new Class II feature, Foggy, enhancing the app’s capabilities with a holistic approach to manage Parkinson’s symptoms. Parky app enables real-time monitoring of symptoms like tremors and dyskinesia through integration with Apple Watch using the Movement Disorder API; with the addition of Foggy, it now offers even more comprehensive support for patients. This innovation is a valuable tool for facilitating the exchange of meaningful and reliable data between patients and medical professionals, aiding in a better understanding and management of the disease.
Contact Information:
Bulutay Gunes
Brand Manager
Gokce Temizas
Commercial Officer
Original Source:
h2o Announces FDA Listing of Apple Watch-Based Cueing Feature ‘Foggy’ for Freezing of Gait in Parkinson’s Disease
Throtle’s Data Pixel Technology to Enhance HealthVerity Media Measurement and Audience Manager Solutions
HealthVerity to enhance its Media Measurement and Audience Manager solutions using Throtle’s data pixel technology for precise campaign targeting and attribution.
RED BANK, N.J., April 11, 2024 (Newswire.com)
–
Throtle, healthcare’s only dedicated identity company, announced today its data pixel technology will be used by HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the science. Throtle’s pixel technology will enhance HealthVerity Media Measurement, a campaign attribution solution, as well as Audience Manager for precision targeting. The collaboration promises to provide unparalleled data insights for improved campaign efficacy.
Throtle’s powerful pixel technology enables the capture of valuable traffic data, which is then matched against their proprietary healthcare identity graph. The integration of these datasets allows for Throtle ID (TID) generation, a unique identifier that provides deep insights into customer behavior and campaign performance.
In turn, HealthVerity has established the nation’s largest privacy-protected healthcare data ecosystem by assigning patients a unique but persistent identifier, known as a HealthVerity ID (HVID), that allows patient identities to be accurately resolved over time and across data sources in a HIPAA-compliant manner. Media Measurement synchronizes the TID and HVID to provide the most comprehensive view of the patient journey that includes ad impressions and actual patient behavior, allowing for real-time campaign attribution and optimization. Using Audience Manager, self-directed analytics can be performed, while remaining HIPAA compliant, to gain a deeper understanding of patient behavior and more precisely target optimal audience segments.
The Throtle and HealthVerity collaboration unlocks a myriad of measurement use cases, enabling an unprecedented level of analysis and optimization for healthcare marketing efforts. This collaboration not only enhances the accuracy of campaign measurement, but also empowers marketers to make data-driven decisions, ensuring their messages reach the right audience at the right time with the right impact.
“Throtle is thrilled to collaborate with HealthVerity to bring our advanced identity resolution capabilities to the forefront of healthcare marketing,” said Chris Neuner, President of Throtle. “By leveraging our data pixel technology, HealthVerity can offer their clients a deeper understanding of their campaign performance and audience engagement, setting a new standard for precision in healthcare marketing analytics.”
Andrew Kress, CEO of HealthVerity, also expressed enthusiasm about the relationship, stating, “By synchronizing Throtle’s leading consumer identity resolution with our best-in-class patient identity resolution, our Media Measurement and Audience Manager solutions can provide pharmaceutical companies with previously unattainable insights. Working with Throtle is a testament to our commitment to innovation and our continuous effort to provide the life sciences industry with cutting-edge solutions that drive better outcomes for everyone involved.”
This collaboration brings together the strengths of identity resolution and data synchronization to deliver superior insights on the patient journey. As both companies continue to push the boundaries of what is possible in healthcare data analytics, the industry can look forward to more personalized, efficient, and effective marketing strategies that benefit healthcare providers and patients alike.
Contact Information:
Maggie Jordan
CSO
Original Source:
Throtle’s Data Pixel Technology to Enhance HealthVerity Media Measurement and Audience Manager Solutions